CRIS sentiment intelligence

Curis has consented 10 CLL patients; first five expected to dose by July's end

Tone

Neutral 50/100

Event

Market update

Published

22 Jul 2026 11:00

Source

Stock Titan

Q1 Earnings Highs And Lows: Natera (NASDAQ:NTRA) Vs The Rest Of The Biotechnology Stocks

Tone

Neutral 50/100

Event

Earnings

Published

16 Jul 2026 18:49

Source

Market source

Equity in earnings of Curis, Inc. – SWB:CUS1

The article provides financial information for Curis, Inc. (SWB:CUS1), specifically focusing on its equity in earnings, with data sourced from ICE Data Services and FactSet. It indicates that the market for this stock is currently closed, with no trades reported.

Tone

Neutral 50/100

Event

Earnings

Published

16 Jul 2026 05:40

Source

TradingView

Long term debt to total equity ratio of Curis, Inc. – SWB:CUS1

This article focuses on the long-term debt to total equity ratio of Curis, Inc. (SWB:CUS1) as presented on TradingView. It appears to be a financial data page rather than a traditional article, providing a snapshot of this key financial metric for the biotechnology company. The c

Tone

Neutral 50/100

Event

Balance sheet

Published

15 Jul 2026 04:12

Source

TradingView

Price to book forward of Curis, Inc. – SWB:CUS1

This article provides financial information for Curis, Inc. (SWB:CUS1), specifically focusing on its price-to-book forward ratio. It's listed on the Stuttgart Stock Exchange under Health Technology/Biotechnology. The page displays general financial data, with market data provided

Tone

Neutral 50/100

Event

Market update

Published

14 Jul 2026 22:16

Source

TradingView

Unpacking Q1 Earnings: Incyte (NASDAQ:INCY) In The Context Of Other Biotechnology Stocks

Tone

Neutral 50/100

Event

Earnings

Published

13 Jul 2026 07:00

Source

Market source

Curis, Inc. (CUS1) Company Information

This article provides company information for Curis, Inc. (CUS1), detailing its exchange listings, key information such as its ticker, industry, sector, and market capitalization, and sources of financial data. It also lists the number of employees, location, and the analysts who

Tone

Neutral 50/100

Event

Market update

Published

12 Jul 2026 05:10

Source

Simply Wall Street

Net margin % of Curis, Inc. – DUS:CUS1

This article provides the net margin percentage for Curis, Inc. (DUS:CUS1) on the TradingView platform. It shows the value and change over a period, indicating financial performance. The data is part of a larger financial overview for the company available on the platform.

Tone

Neutral 50/100

Event

Earnings

Published

10 Jul 2026 16:40

Source

TradingView

Curis (CRIS) director John Hohneker receives 6,800 stock options at $5.29

Curis Inc. director John Hohneker was granted 6,800 non-qualified stock options with an exercise price of $5.29 per share. These options, which relate to 6,800 shares of common stock, will vest entirely on July 7, 2027, and have an expiration date of July 6, 2036. This transactio

Tone

Neutral 50/100

Event

Market update

Published

10 Jul 2026 01:40

Source

Stock Titan

Curis (CRIS) CDO Jonathan Zung receives 48,285 stock options at $5.29 strike

Jonathan B. Zung, Chief Development Officer of Curis Inc. (CRIS), was granted 48,285 employee stock options with an exercise price of $5.29 per share. These options are part of his compensation, designed to vest over time with 25% vesting on July 7, 2027, and subsequent quarterly

Tone

Neutral 50/100

Event

Market update

Published

09 Jul 2026 20:14

Source

Stock Titan

CURIS (CRIS) CFO receives 48,285 stock options at $5.29 exercise price

CURIS (CRIS) CFO Diantha Duvall was granted 48,285 employee stock options with an exercise price of $5.29 per share as part of her compensation. The options will vest over time, with 25% vesting on July 7, 2027, and subsequent quarterly vesting until July 7, 2030, and will expire

Tone

Neutral 50/100

Event

Market update

Published

09 Jul 2026 20:14

Source

Stock Titan

CURIS INC (CRIS) director granted 6,800 non-qualified stock options at $5.29

CURIS INC director Anne Elizabeth Borgman was granted 6,800 non-qualified stock options with an exercise price of $5.29 per share. These options will vest 100% on July 7, 2027, and have an expiration date of July 6, 2036. This grant represents compensation-related equity rather t

Tone

Neutral 50/100

Event

Market update

Published

09 Jul 2026 20:14

Source

Stock Titan

Curis (CRIS) director receives grant of 6,800 non-qualified stock options

Curis Inc. director Kenneth I. Kaitin received a grant of 6,800 non-qualified stock options, exercisable at $5.29 per share. These options, which vest fully on July 7, 2027, and expire on July 6, 2036, are a compensation-related equity award rather than an open-market transaction

Tone

Neutral 50/100

Event

Market update

Published

09 Jul 2026 20:14

Source

Stock Titan

Price to book forward of Curis, Inc. – HAM:CUS1

This article provides financial information for Curis, Inc. (HAM:CUS1), specifically focusing on its "Price to book forward" metric. The content appears to be a financial data snippet from TradingView, indicating that the market for HAM:CUS1 is currently closed with no trades.

Tone

Neutral 50/100

Event

Market update

Published

09 Jul 2026 20:14

Source

TradingView

Director Marc Rubin receives 6,800 Curis (CRIS) stock options at $5.29

Curis Inc. director Marc Rubin was granted 6,800 non-qualified stock options at an exercise price of $5.29 per share. These options will vest 100% on July 7, 2027, and have an expiration date of July 6, 2036. This transaction is considered a compensation-related award rather than

Tone

Neutral 50/100

Event

Market update

Published

09 Jul 2026 20:14

Source

Stock Titan

Form 4 Curis Inc For: 9 July By Investing.com

This article reports on a Form 4 filing for Curis Inc. (CRIS) dated July 9th. Form 4 filings are used to disclose changes in beneficial ownership of a company's securities by officers, directors, and 10% shareholders. The specific details of the Form 4 are not provided beyond the

Tone

Neutral 50/100

Event

Market update

Published

09 Jul 2026 20:14

Source

Investing.com Canada

Curis Inc (CRIS) director receives 6,800 stock options at $5.29

Curis Inc. director Martyn D. Greenacre was granted 6,800 non-qualified stock options with an exercise price of $5.29 per share. These options expire on July 6, 2036, and will vest completely on July 7, 2027. This transaction, categorized as an "A" grant, links the director's com

Tone

Neutral 50/100

Event

Market update

Published

09 Jul 2026 20:14

Source

Stock Titan

Curis (CRIS) CEO receives 110,090 employee stock options at $5.29

Tone

Neutral 50/100

Event

Market update

Published

09 Jul 2026 07:00

Source

Stock Titan

Free cash flow per share of Curis, Inc. – LSX:A42DTL

This article provides financial information for Curis, Inc. (LSX:A42DTL), specifically focusing on its free cash flow per share. It is presented on TradingView, a platform offering market data and financial tools.

Tone

Neutral 50/100

Event

Balance sheet

Published

08 Jul 2026 23:12

Source

TradingView

Price to book forward of Curis, Inc. – FWB:CUS1

The article "Price to book forward of Curis, Inc. – FWB:CUS1" appears to be a stub or a placeholder page from TradingView, specifically concerning the financial metrics of Curis, Inc. (CUS1) on the Frankfurt Stock Exchange. It indicates that there is currently no trade data avail

Tone

Neutral 50/100

Event

Market update

Published

08 Jul 2026 18:12

Source

TradingView

Price to book forward of Curis, Inc. – MUN:CUS1

This article provides financial information for Curis, Inc. (MUN:CUS1) on the Munich Stock Exchange, specifically focusing on its price-to-book forward ratio. It indicates that the market is closed with no recent trades. The content is primarily a data placeholder within a larger

Tone

Neutral 50/100

Event

Market update

Published

08 Jul 2026 09:40

Source

TradingView

Basic earnings per share (basic EPS) of Curis, Inc. – MUN:CUS1

This page provides financial data, specifically the basic earnings per share (basic EPS), for Curis, Inc. trading under the symbol CUS1 on the Munich Stock Exchange. The current market status is closed with no recorded trades.

Tone

Neutral 50/100

Event

Earnings

Published

07 Jul 2026 19:13

Source

TradingView

Curis, Inc. Financial Statements – MUN:CUS1

This article provides financial statement insights for Curis, Inc. (MUN:CUS1), a biotechnology company focused on developing drug candidates for human cancers. It highlights key facts such as the company's founding in 2000 and its headquarters in Lexington, MA, along with its pip

Tone

Neutral 50/100

Event

Market update

Published

07 Jul 2026 18:40

Source

TradingView

Curis Inc (STU:CUS1) Stock Price & 30 Year Financial Data

This article provides 30-year financial data for Curis Inc (STU:CUS1), including detailed growth rates for revenue, EPS, EBIT, EBITDA, free cash flow, and stock price performance. It presents key financial metrics such as market cap and enterprise value, along with various financ

Tone

Neutral 50/100

Event

Earnings

Published

07 Jul 2026 11:13

Source

GuruFocus

Curis Inc (STU:CUS1) Stock Earnings Transcripts

This page provides a comprehensive list of Curis Inc (STU:CUS1) earnings call, extraordinary shareholders meeting, and conference call transcripts dating back to 2018. It includes financial data such as market cap, enterprise value, and various ratios, alongside stock performance

Tone

Neutral 50/100

Event

Earnings

Published

07 Jul 2026 11:13

Source

GuruFocus